Drugs / FP9 ME-TRAP
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00408668 | Aug 2005 → Feb 2006 | Plasmodium falciparum malaria | University of Oxford | Completed | No outcome recorded |
| Phase 1/2 | NCT00121823 | Jun → Dec 2004 | malaria | London School of Hygiene and Tropical Medicine | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | FP9 ME-TRAP | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00121823 ↗ |
| Modality | Vaccine | “Two of the vaccines ('FP9 ME-TRAP' and 'MVA ME-TRAP') have been designed at the University of Oxford.” NCT00408668 ↗ |